| EDIC. Patient status of participants with Type 1 diabetes and involved in the \"Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications Study (EDIC)\" project. | B1a. Information on transfer to inactive status. Judgment of Principal Investigator and Study Coordinator that participation in the study could not longer be considered informed or would be directly injurious to the patient's well-being | phv00051638.v1.p1 |
| The dataset represents variables used for a comparison of neuropsychological functions of DCCT volunteers who received standard diabetes treatment to those who received experimental diabetes treatment, at baseline and years 2, 5, 7 and close-out. Neuropsychological testing focused on cognitive functions (e.g. general intelligence, problem-solving, calculation skills, learning and memory ability), attention and manual dexterity. Adults were tested with the Wechsler Adult Intelligence Scale and children with the Wechsler Intelligence Scale for children (see also pht000270, ms7exgee; for published results see: <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8554246?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\"> PMID 8554246</a>). | Visual reproductions - long term memory/delayed recall: total score (quarterly visit 00) | phv00024963.v1.p1 |
| The dataset represents data collected for the ms7exf10 dataset (comparison of neuropsychological functions of DCCT patients, comparing those receiving standard to those receiving experimental diabetes treatment; with or with minimal - baseline retinopathy or nephropathy, collected at baseline to that at years 2, 5, 7 and close-out); in ms7exgee the data were analyzed with a screening algorithm that allows determination of performance changes in comparison to baseline assessment, and identification of volunteers who might be at risk of losing cognitive function (for published results see <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8554246?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\"> PMID 8554246</a>). | Indicator: intensive treatment group | phv00031784.v1.p1 |
| The dataset represents variables used to collect annual information about e.g. diabetes management, adherence to treatment plan, diabetes-related complications, usage of (non-diabetes) medications, general physical and lifestyle measurements (e.g. height, weight, smoking, exercise), medical history, and socio-economic information (used through September '90). | Patient's job status changed | phv00028979.v1.p1 |
| EDIC. Cardiovascular disease of participants with Type 1 diabetes and involved in the \"Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications Study (EDIC)\" project. | C1. Chest pain: left arm | phv00066205.v1.p1 |
| The dataset represents variables that provide further information of volunteers deemed eligible following the initial clinic visit (see also pht000249, form 1) about e.g. their diabetes history and management, diabetes-related complications, usage of (non-diabetes) medications, general medical history (including lifestyle measurements such as weight, smoking, exercise), family medical history, and socio-economic information. Data were collected at eligibility screening. | Patient has a history of: dizziness upon standing | phv00034386.v1.p1 |
| The dataset represents variables used for a comparison of the occurrence of macrovascular disease and risk factors (e.g. cerebro-vascular disease, coronary arterial disease, peripheral vascular disease, death) in DCCT volunteers randomized to the standard versus those randomized to the experimental group (for published results see <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7732997?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\"> PMID 7732997</a>). Average follow-up time was 6.5 years. (1) Detailed Record of macrovascular events (see also: (2) Repeated measures of putative risk factors, pht000257, ms5event) | Indicator: sustained triglycerides > 200 observed | phv00027851.v1.p1 |
| The dataset represents variables used to collect annual information about e.g. blood glucose levels, serum lipid values, kidney functions (e.g. GFR, urine quality [e.g. creatinine and sodium content, pH, volume]). - Year 8 values | CBL8: 24-hr urine: sodium (meq/l) | phv00031077.v1.p1 |
| EDIC. Diabetic ketoacidosis of participants with Type 1 diabetes and involved in the \"Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications Study (EDIC)\" project. | C4a. Nature of event. Was the patient treated within a health care facility: emergency room | phv00051435.v1.p1 |
| The dataset represents variables used to collect information about CNS functions, e.g. cognitive and motor functions, including memory, attention, arithmetic, verbal abilities, tactile abilities, and motor coordination. Data were collected at baseline, years 2, 5, 7 and close-out (see also pht000265, form 13). | WAIS digit span: number of points | phv00032288.v1.p1 |
| This dataset represents variables of the SF-36 questionnaire that assess general physiological and psychological health (e.g. current health status, work performance, social life) as experienced and evaluated by the volunteer at the time of close-out. | Well-being: mental health | phv00028475.v1.p1 |
| The dataset represents variables used to collect information at randomization and at quarterly follow-up visits. The variables represent information about diabetes management, adherence to treatment plan, diabetes-related complications, usage of (non-diabetes) medications, general physical and lifestyle measurements (e.g. height, weight, smoking, exercise). (Used through September '90) | Infusion pump: postprandial - number of self blood glucose monitorings that should have been done | phv00029686.v1.p1 |
| The dataset represents variables used to collect annual information about e.g. blood glucose levels, serum lipid values, and kidney functions (e.g. GFR, urine quality [e.g. creatinine and sodium content, pH, volume]). - Year 7 values | CBL7: Lipid test - 21: collection date | phv00028558.v1.p1 |
| The dataset represents variables used to compare the effects of standard versus experimental treatment on the development and/or progression of diabetic retinopathy. The retinal health status (e.g. presence/absence of macular edema, microaneurysms, neovascularization, hemorrhages) was monitored through seven-field stereoscopic fundus photographs which were taken bi-annually and graded using the ETDRS scale (for published results see: <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7826293?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\"> PMID 7826293</a>). | Presence (1) or absence (0) of new vessels on disc (either eye) - quarterly visit 20 | phv00033679.v1.p1 |
| The dataset represents variables used to collect information about CNS functions, e.g. cognitive and motor functions, including memory, attention, arithmetic, verbal abilities, tactile abilities, and motor coordination. Data were collected at baseline, years 2, 5, 7 and close-out (see also pht000265, form 13). | WAIS object assembly: total points | phv00032205.v1.p1 |
| The dataset represents variables that provide information about blood glucose profiles collected at baseline, quarterly visits, and close-out. Measurements include C-peptide, creatinine, glucose, and cholesterol (total, HDL, LDL) levels. | Post-supper blood glucose at OD 340 (quarterly visit 15) | phv00032995.v1.p1 |
| The dataset represents variables used for a comparison of the occurrence of macrovascular disease and risk factors (e.g. cerebro-vascular disease, coronary arterial disease, peripheral vascular disease, death) in DCCT volunteers randomized to the standard versus those randomized to the experimental group (for published results see <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7732997?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\"> PMID 7732997</a>). Average follow-up time was 6.5 years. (1) Detailed Record of macrovascular events (see also: (2) Repeated measures of putative risk factors, pht000257, ms5event) | Polyunsaturated fat (% calories): quarterly visit 20 | phv00027768.v1.p1 |
| The dataset represents variables used to collect annual information about e.g. blood glucose levels, serum lipid values, kidney function (e.g. GFR, urine quality [e.g. creatinine and sodium content, pH, volume]). - Year 3 values | CBL3: 24-hr urine: creatinine coefficient (mg/kg/spec) | phv00030393.v1.p1 |
| The dataset represents variables used to collect annual information about e.g. diabetes management, adherence to treatment plan, diabetes-related complications, usage of (non-diabetes) medications, general physical and lifestyle measurements (e.g. height, weight, smoking, exercise), medical history, and socio-economic information (used through September '90). | MDI: bedtime - number of self blood glucose monitorings actually done | phv00028896.v1.p1 |
| EDIC. Medical history and physical exam of participants with Type 1 diabetes and involved in the \"Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications Study (EDIC)\" project. | Q10. Physical examination, abnormality of pelvis | phv00065919.v1.p1 |